Novartis muscle wasting drug gets `breakthrough` status

Novartis said on Tuesday U.S. regulators have granted breakthrough therapy status for its investigational compound bimagrumab for the potential treatment of patients with sporadic inclusion body myositis (sIBM).

Novartis, BioE join hands for typhoid, paratyphoid vaccines

Switzerland-based drug major Novartis today said it has entered into a development and licensing agreement with Biological E (BioE) for two vaccines against typhoid and paratyphoid fevers.

US sues Novartis for paying kickbacks

The US Justice Department on Friday accused drug maker Novartis of paying kickbacks to doctors to prescribe the company`s drugs over rival products.

Pharma giant Novartis working on H7N9 vaccine

Swiss pharmaceuticals giant Novartis is researching a vaccine for the H7N9 strain of bird flu, its chief executive said today, amid fears that the disease could mutate into a form that spreads among people.

New jab for `deadly` meningitis could save thousands of lives

A vaccine against a deadly form of meningitis has been approved for use in the UK.

SC again asks Novartis to cut cancer drug price

The Supreme Court Wednesday once again asked pharma company Novartis to scale down the price of its cancer drug Glivec, made from compound imatinib mesylate.

Alembic resolves generic capsules` patent case with Novartis

Alembic Pharmaceuticals today said it along with Breckenridge Pharmaceutical Inc, USA has settled patent case with Novartis for Rivastigmine Tartrate capsules.

US delays decision on Novartis’ meningitis drug

US authorities have asked Novartis for more information on its meningitis vaccine Menveo, holding up the company`s application to extend the use of the drug to American toddlers and infants, the Swiss drugmaker said on Monday.

Novartis drug investigated after 11 deaths

A European agency is investigating a multiple sclerosis drug to determine whether the medicine played any role in the deaths at least 11 patients.

Swiss pharmaceutical firm Novartis recalls drugs

Novartis is recalling all lots of select bottle packaging configurations from retailers of Excedrin and NoDoz products.

Novartis plans to buy rest of Alcon for $39 bln

Switzerland`s Novartis plans to get full control of eye care group Alcon for a total $39.3 billion, to diversify away from prescription drugs, after agreeing to acquire a majority stake from Nestle.

SC issues notices to Centre, others on Novartis petition

The Supreme Court on Friday issued notices to the Centre, pharma major Cipla, Ranbaxy Lab, Hetero Drugs, Natco Pharma and others on a petition filed by Novartis AG challenging the denial of patent for its blood cancer drug.

Novartis starts testing its swine flu vaccine

Swiss drug maker Novartis has begun
injecting its swine flu vaccine into people in the company`s
first human tests, a spokesman said on Wednesday.

Novartis starts testing its swine flu vaccine

Swiss drug maker Novartis has begun
injecting its swine flu vaccine into people in the company`s
first human tests, a spokesman said on Wednesday.